Bringing Digital Pathology to Life
Aperio Expands Leadership Position in Digital Pathology Market
ScanScope™ Scanners and Spectrum™ Information Management Software Gold Standard for Digital Pathology
Vista, CA– May 24, 2007 A global leader in digital pathology for the healthcare and life sciences industry, Aperio now has an installed base of more than 250 systems in 23 countries, including more than half of the top 13 pharmaceutical companies and more than two-thirds of the top 14 rated U.S. hospitals, per the 2006 U.S. News & World Report, Best Hospitals. Among some of the hospitals and health systems using Aperio are Duke University Medical Center, Massachusetts General Hospital, Mayo Clinic, and Stanford Hospitals and Clinics. A partial list of pharmaceutical customers includes Novartis, GlaxoSmithKline, Eli Lilly, Sanofi-Aventis and Amgen.
Aperio is the gold standard in digital pathology solutions, serving markets that include pre-clinical research, basic research and education. Aperio also offers a full product solution for clinical organizations with applications in telepathology, quality assurance, archival and retrieval (PACS) and automated image analysis. Aperio's solutions enable users to achieve greater efficiency and cost savings by improving workflow processes and expanding data access, integration and reporting capabilities.
Aperio's award-winning and patented linear array-based ScanScope slide scanning systems, which include image analysis algorithms for quantitative analysis, deliver unprecedented performance to create seamless, true color whole slide images at giga-pixel resolution from an entire glass slide in a matter of minutes. Aperio's slide scanning systems are offered with Spectrum information management software to enable the viewing, analysis and management of digital slides and other images in a secure multi-user, multi-site environment.
Dirk Soenksen, CEO of Aperio commented, "We're proud of being the company that has, and continues to, set the high water mark in the emerging digital pathology market. Our team is committed to developing digital pathology solutions that meet the evolving needs of pathologists and laboratories around the world. Aperio was the first to offer an ultra-fast slide scanning system with oil-immersion optics to provide hematopathologists and microbiologists with the ability to digitize specimens at the highest resolutions. We also continue to forge relationships with respected international partners to help customers world-wide realize the productivity benefits of going digital, and are seeing overwhelming response to our technology in global markets."
Aperio sponsors annual Pathology Visions conferences for digital pathology best practices in education, research and clinical applications held in both the U.S. and European communities. This year's third annual 2007 Visions conference will be held October 21-23 in San Diego, CA to address a range of topics related to the rapidly growing digital pathology market. The European conference is December 3-5 in Amsterdam. For registration information, visit pathologyvisions.com or Aperio.com.
About Aperio Technologies, Inc.
Aperio provides systems and services for digital pathology. Our award-winning ScanScope® slide scanning systems and SpectrumTM digital pathology information management software is helping pathology professionals around the world improve the efficiency and quality of pathology services, enhance patient care, and improve the bottom line. Applications include remote viewing, archival and retrieval, digital conferencing, research and education, and image analysis. For more information and to view a gallery of digital slides created by ScanScope Systems, visit www.aperio.com.
# # #
ScanScope® and SpectrumTM are trademarks of Aperio Technologies.
